Medicine
The first FDA-approved clinical trial of psilocin has begun
“This has never been done before,” says Filament’s CEO.
Nasal COVID-19 vaccines prepare for infection right where it starts – in your nose and throat
Intranasal vaccines are best suited to protect against pathogens that enter through the nose, like the flu or the coronavirus.
After death, you’re aware that you’ve died, say scientists
How can we know that we're dead after we die? Some evidence attributes a certain neurological phenomenon to a near death experience.
An old HIV drug may treat Down syndrome
A common HIV drug could potentially be a Down syndrome treatment, improving cognition in mouse models of the condition.
Nanoparticles may automatically clean your teeth one day
Shapeshifting nanoparticles may one day lead to automated oral care.
FDA may soon allow pig organ transplant trials
With pig transplantation looking increasingly viable, the FDA may soon allow clinical trials of the technique to begin.
Psychedelic research returns to Veterans Affairs
After decades, the Department of Veterans Affairs is once again investigating psychedelic therapies.
Universal flu vaccine enters phase 1 trials
NIAID researchers have begun a phase 1 trial of a new universal vaccine candidate that was promising in animal challenge studies.
A new delivery method for drugs that can’t withstand stomach acid
In order for a drug to get to the small intestine, it must first get past the highly acidic environment of the stomach.
Two FDA-approved drugs may improve Alzheimer’s symptoms
A retrospective study found that Alzheimer’s symptoms improved in patients who took two FDA-approved drugs that treat psychiatric disorders.